Furosemide
- 139 trials, none about aging, 61 with no results posted
- Humans1
Trials
0 about aging, of 139Approved
Jul 1, 1966DiscontinuedEdema, Hypertension, Nephrotic Syndrome, Congestive Heart Failure, renal disease, cirrhosis of the liver
Mar 20, 1968Discontinued
Mar 8, 1977Discontinued
Jan 10, 1979Discontinued
May 19, 1981Edema, Heart Failure, Nephrotic Syndrome, Pulmonary Edema, renal disease, cirrhosis of the liver
Aug 27, 1981Discontinued
All 27Fewer
Repurposing
Phase 3Results posted1 trial
Phase 4Results posted4 trials
Phase 4Completed4 trials
Phase 3Recruiting1 trial
Phase 3Results posted1 trial
Phase 4Completed1 trial
40 of 64Fewer
In trials
Pregnancy-Induced Hypertension
Phase 4Terminated4 trials
Bronchiolitis
Phase 3Completed2 trials
Transient Tachypnea of the Newborn
Phase 3Completed2 trials
Cutaneous Warts
Phase 2Completed2 trials
Respiratory distress syndrome
Phase 2Results posted2 trials
Readouts due
- Mar 15, 2027
- Apr 1, 2027
- Aug 2027
Stopped
NCT02458157TerminatedEdema
Very low recruitment rates
NCT03731117TerminatedAcute kidney injury
Study end date exceeded and insufficient number of subjects needed for analysis. 11 patients included / 70 theoretical patients
NCT05158153TerminatedAcute kidney injury
Inadequate recruitment
NCT04343235TerminatedPregnancy-Induced Hypertension
Challenges with enrollment; primary investigator left the institution
NCT03170219TerminatedAcute heart failure
Slow enrollment
NCT03362515TerminatedNasal polyps
The study was terminated prematurely due to low enrollment numbers and the development of better drugs to treat polyps (ie. Biologics) which were not available when the study began.
All 7Fewer
Trial sponsors
Company2 trialsPhase 4436 people
Company1 trialPhase 4
Company3 trialsPhase 3597 people
Company1 trialPhase 3393 people
Company3 trialsPhase 2/372 people
Company2 trialsPhase 269 people
Novartis Pharmaceuticals Corporation
Company1 trialPhase 237 people
Company1 trialPhase 1/240 people